Report : South and Central America Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line), Product (Equipment, and Media & Reagent), Application (Drug Discovery, Bioproduction, and Tissue Engineering)
Bioproduction Segment Held Largest Share of Application in South and Central America Cell Line Development Market in 2019
According to a new market research study of ‘South and Central America cell line development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by type, product, and application’ the South and Central America cell line development market is expected to reach US$ 728.17 million in 2027 from US$ 304.25 million in 2019. The market is estimated to grow with a CAGR of 11.7% from 2020-2027. The report provides trends prevailing in the South and Central America cell line development market and the factors driving market along with those that act as hindrances.
Based on application, the cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest share in the market and is expected to dominate the market share during the forecast period, whereas the drug discovery segment is expected to grow at the fastest CAGR during the forecast period. The bioproduction segment's growth is fuelled as many of the market players are offering cell lines for bioproduction purposes. For instance, Creative Biogene provides comprehensive services for generating bioproduction stable cell lines. Creative Biogene has thorough experience at developing bioproduction cell lines that includes robust vector design and construction, gene synthesis, gene delivery with high efficiency, and rigorous Q&C system etc. Additionally, the drug discovery segment is estimated to register the highest CAGR during the forecast period due to the fact that cell-based assays are crucial for pre-clinical drug development. Cell lines have emerged as a tool for understanding and assessing the characteristics of the new drug candidates. Many organizations like ATCC provides a wide collection of cell lines in order to investigate the efficacy and safety of new drug molecules for applications like high content screening, 3D culture, cytotoxicity and receptor-ligand interactions.
The growth of this market is estimated to grow owing to key driving factors such as the growing government initiatives in the cell line development market and an upsurge in the cancer cases across South and Central America. However, the market growth is likely to be hindered owing to the several challenges regarding cell line development.
General Electric, Merck KGaA , and Lonza are among the leading companies operating in the South and Central America cell line development market.
The report segments South and Central America Cell Line Development Market as Follows:
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
By Product
- Equipment
- Media & Reagent
By Application
- Drug Discovery
- Bioproduction
- Tissue Engineering
By Country
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com